Hôpital Foch

Futó vizsgálatok

• Még nem toboroz

  Evaluation of the Effect of Time of Administration on the Activity on First Line of Pembrolizumab in Association With Carboplatin-pemetrexed in Metastatic Non-squamous Lung Cancer. A Randomised Multicenter Phase III Trial

  NCT07915037· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis

  2026-526404-71-00· 2. fázis· Agomab Spain S.L.U.· Forrás

• Még nem toboroz

  A Phase 3 Open-Label, Randomized Controlled Trial of T-bren (BL-M07D1) vs. Platinum-based Chemotherapy in Patients with HER2-expressing metastatic urothelial cancer with disease progression on or after anti-PD-(L)1-based therapy

  2026-527617-29-00· 3. fázis· Systimmune Inc.· Forrás

• Toboroz

  A Study of DS-3939a in Participants With Solid Tumors

  NCT07739966· 1/2. fázis· Daiichi Sankyo· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  NCT07541170· 3. fázis· Hoffmann-La Roche· Forrás

• Még nem toboroz

  Tenecteplase for the treatment of acute stroke in the late time window before inter-hospital transfer for thrombectomy: a randomized controlled trial

  2026-525280-40-00· 3. fázis· Fondation A De Rothschild· Forrás

• Toboroz

  ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment

  2025-523307-29-00· 3. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

  NCT07420439· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Még nem toboroz

  Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial

  NCT07721363· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality for Lung Cancer

  NCT07828938· Fondation Hôpital Saint-Joseph· Forrás

• Még nem toboroz

  Immunotherapy with a JAK1/JAK2 inhibitor (baricitinib) and an mTORC1 inhibitor (sirolimus), alone and in combination, for the control of HIV-1 replication after antiretroviral treatment interruption: a phase II multicenter, multi-arm, multi-stage, randomized, double-blind, placebo-controlled, adaptative trial

  NCT07081763· 2. fázis· ANRS Maladies Infectieuses Emergentes· Forrás

• Még nem toboroz

  Impact of discontinuation of long-term macrolides in stable Non Cystic Fibrosis Bronchiectasis : a multicenter randomized controlled trial

  2025-521493-33-00· 3. fázis· Centre Hospitalier Intercommunal Creteil· Forrás

• Toboroz

  A study to find out if enfortumab vedotin given with pembrolizumab helps people with muscle-invasive bladder cancer keep their bladder.

  2025-524488-18-00· 2. fázis· Astellas Pharma Global Development Inc.· Forrás

• Toboroz

  A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

  NCT07566052· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis

  NCT07720375· 2. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  Personalizing chemotherapy selection after surgery for patients with stage III colorectal cancer using a blood test

  2025-521045-24-00· 3. fázis· Unicancer· Forrás

• Toboroz

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

  NCT07659782· 2. fázis· Verastem, Inc.· Forrás

• Toboroz

  A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

  NCT07516951· 2. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])

  NCT07666490· 4. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  NCT07284602· 3. fázis· PureTech· Forrás

• Toboroz

  A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer

  2025-522818-23-00· 3. fázis· Zai Lab (US) LLC· Forrás

• Fut, nem toboroz

  A global study of volrustomig (MEDI5752) plus chemotherapy versus pembrolizumab plus chemotherapy for participants with metastatic non-small cell lung cancer.

  2023-503298-39-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation Recipients

  NCT07771855· 2. fázis· Hopital Foch· Forrás

• Toboroz

  A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

  NCT07189325· 3. fázis· University Hospital, Montpellier· Forrás

• Még nem toboroz

  Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicenter Randomized Controlled Trial (IVT-ALL-IN)

  NCT07603440· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Toboroz

  Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.

  NCT07333066· 3. fázis· Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD· Forrás

• Toboroz

  A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)

  2025-521587-35-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Még nem toboroz

  Interaction Between Decidual Cells and NK Cells in Endometriosis

  NCT07652593· Hopital Foch· Forrás

• Toboroz

  A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

  NCT07513376· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )

  2024-519818-31-01· 3. fázis· Genmab A/S· Forrás

• Toboroz

  A Study to Evaluate Brenipatide Compared with Placebo in Adult Participants with Uncontrolled Moderate to Severe Asthma

  2025-522640-41-00· 2. fázis· Eli Lilly & Co.· Forrás

• Toboroz

  Home Treatment of Patients With Active Cancer and Acute Pulmonary Embolism Without HESTIA Criteria.

  NCT07315347· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.

  NCT07451847· 4. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.

  NCT07379957· University Hospital, Bordeaux· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  NCT07221357· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis

  NCT06940661· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Toboroz

  Withdrawal of Dupilumab in Severe Asthma

  NCT06818019· 4. fázis· University Hospital, Toulouse· Forrás

• Toboroz

  A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

  NCT07218146· 3. fázis· Zai Lab (Shanghai) Co., Ltd.· Forrás

• Toboroz

  A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  NCT07213674· 3. fázis· Amgen· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

  NCT07166094· 3. fázis· Genmab· Forrás

• Toboroz

  A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

  NCT07227402· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer

  NCT07001618· 2. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás

• Toboroz

  A randomized multicenter Phase II trial evaluating oral pooled fecal microbiotherapy (MaaT033) concomitant to Cemiplimab (CB) versus best investigator’s choice (BIC) in resistance to PD-1/PD-L1 blockade due to antibiotics (ATB) uptake in patients with advanced non-small cell lung cancer (NSCLC) - IMMUNOLIFE2

  2024-517018-14-00· 2. fázis· Institut Gustave Roussy· Forrás

• Toboroz

  Phase 3 Study of Xaluritamig Plus Abiraterone vs Investigator's Choice in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  2025-520555-89-00· 3. fázis· Amgen Inc.· Forrás

• Toboroz

  Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

  NCT06656598· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Fut, nem toboroz

  A Study of Subcutaneous Nivolumab plus Intravenous Ipilimumab and Chemotherapy in Participants with Previously Untreated Metastatic or Recurrent NSCLC

  2024-520108-25-00· 2. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás

• Toboroz

  A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  NCT07219173· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

  NCT06529718· 2. fázis· UNICANCER· Forrás

• Fut, nem toboroz

  Study of zoldonrasib in Previously Treated Patients with RAS G12D-Mutant Non-Small Cell Lung Cancer (NSCLC)

  2025-521681-10-00· 2. fázis· Revolution Medicines Inc.· Forrás

• Toboroz

  Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma

  NCT07028125· 4. fázis· Centre Francois Baclesse· Forrás

Showing 50 of 179.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák31 toboroz
• Stroke (szélütés)12 toboroz
• Prosztatarák9 toboroz
• Asztma6 toboroz
• Hólyagrák6 toboroz
• Vesedaganat6 toboroz
• Vastagbélrák5 toboroz
• ANCA-asszociált vasculitis4 toboroz
• Bronchiectasis4 toboroz
• Cisztás fibrózis4 toboroz
• Idiopátiás tüdőfibrózis4 toboroz
• Méhtestrák4 toboroz
• Glioblasztóma3 toboroz
• Gyomor- és nyelőcsőrák3 toboroz
• Máj- és epeúti rák3 toboroz
• Sclerosis multiplex (SM)3 toboroz
• Brain aneurysm2 toboroz
• Endometriózis2 toboroz
• Lupus (SLE)2 toboroz
• Myocarditis2 toboroz
• Petefészekrák2 toboroz
• Fej-nyaki daganatok1 toboroz
• Gyermekkori daganatok1 toboroz
• Hasnyálmirigyrák1 toboroz
• HIV-fertőzés1 toboroz
• Időskori makuladegeneráció1 toboroz
• IgA-nefropátia1 toboroz
• Koszorúér-betegség1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Krónikus vesebetegség1 toboroz
• Liver cirrhosis1 toboroz
• Neuroendokrin daganatok1 toboroz
• Neuromyelitis optica (NMOSD)1 toboroz
• Sarcoidosis1 toboroz
• Spinal cord injury1 toboroz
• Szarkóma1 toboroz
• Tripla negatív emlőrák1 toboroz

Lezárt vizsgálatok

• Fut, nem toboroz

  Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

  2025-521115-40-00· 2. fázis· Bicycletx Limited· Forrás

• Toboroz

  Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Pancreatic Cancer (Substudy PDAC)

  2024-517819-74-00· 1/2. fázis· Merck Healthcare KGaA· Forrás

• Lezárult

  A trial to learn how well benralizumab works and how safe it is when given in addition to standard asthma treatments in people with eosinophilic asthma

  2024-515162-13-00· 3. fázis· AstraZeneca AB· Forrás

• Lezárult

  A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients With Acute Ischemic Stroke

  NCT06700824· 2. fázis· Organ, Tissue, Regeneration, Repair and Replacement· Forrás

• Fut, nem toboroz

  Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

  NCT06632951· 2. fázis· AbbVie· Forrás

• Lezárult

  A Study designed to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administered in participants with PD-L1 ≥ 1% TC Stage IIB, IIIA, or select IIIB (T3N2 only) NSCLC following resection and adjuvant platinum-based chemotherapy

  2023-506696-10-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás

• Lezárult

  Glenzocimab in Anterior stroke with Large Ischemic Core eligible for Endovascular therapy

  2023-509615-92-00· 2. fázis· Hopital Fondation Adolphe De Rothschild· Forrás

• Lezárult

  Impact on gastric emptying measured by antral gastric ultrasound of erythromycin administration in stroke patients with indication for mechanical thrombectomy.

  2023-508120-35-00· 4. fázis· Hospital Foch· Forrás

• Lezárult

  A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT05848011· 2. fázis· MacroGenics· Forrás

• Lezárult

  A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide

  NCT05901649· Janssen-Cilag Ltd.· Forrás

• Lezárult

  HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

  NCT05902494· Seagen, a wholly owned subsidiary of Pfizer· Forrás

• Lezárult

  Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate

  NCT05750576· Assistance Publique - Hôpitaux de Paris· Forrás

• Lezárult

  A Study of Two Dose Levels of Vobramitamab Duocarmazine in Participants with Metastatic Castration-resistant Prostate Cancer (TAMARACK)

  NCT05551117· 2. fázis· Macrogenics Inc.· Forrás

• Leállították

  A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

  NCT05678257· 2. fázis· NuCana plc· Forrás

• Lezárult

  REVErsing Airway Remodelling With Tezepelumab

  NCT05651841· 3. fázis· University Hospital, Montpellier· Forrás

• Lezárult

  PRODIGE 81-FFCD 2101-TRIPLET: Study evaluating the benefit of adding Ipilimumab to the combination of Atezolizumab and Bevacizumab in patients with hepatocellular carcinoma receiving first-line systemic therapy-

  2022-501217-31-00· 2/3. fázis· Fondation Franc.Cancerologie Digestive· Forrás

• Lezárult

  Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

  NCT05742802· 3. fázis· AstraZeneca· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

• Lezárult

  Phase 2 Study of MORAb-202 in Previously Treated Metastatic NSCLC AC

  NCT05577715· 2. fázis· Bristol Myers Squibb International Corporation· Forrás

• Lezárult

  Glenzocimab for REperfusion in the Setting of Endovascular Therapy for Brain infarctioN: GREEN Study

  NCT05559398· 2/3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Leállították

  A Study of Nanrilkefusp Alfa (SOT101) in Combination With Cetuximab to Evaluate the Efficacy and Safety in Patients With Colorectal Cancer

  NCT05619172· 2. fázis· SOTIO Biotech AG· Forrás

• Fut, nem toboroz

  Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

  NCT05609578· 2. fázis· Mirati Therapeutics Inc.· Forrás

• Fut, nem toboroz

  Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

  NCT05502237· 3. fázis· Gilead Sciences· Forrás

• Lezárult

  A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults

  NCT05361434· Ipsen· Forrás

• Lezárult

  Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

  NCT05458856· 3. fázis· Ipsen· Forrás

• Lezárult

  A Study of Relatlimab-nivolumab Fixed-dose Combination versus Regorafenib or TAS-102 in Participants with Later-lines of Metastatic Colorectal Cancer

  NCT05328908· 3. fázis· Bristol Myers Squibb International Corporation· Forrás

• Lezárult

  Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis

  NCT05180240· 2. fázis· Cardiol Therapeutics Inc.· Forrás

• Lezárult

  Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

  NCT05153239· 3. fázis· PharmaMar· Forrás

• Leállították

  A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

  NCT05256381· 2. fázis· SOTIO Biotech AG· Forrás

• Lezárult

  Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)

  NCT05030155· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Lezárult

  A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer

  NCT05337137· 1/2. fázis· Bristol-Myers Squibb· Forrás

• Fut, nem toboroz

  Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients

  NCT05074810· 1/2. fázis· Verastem, Inc.· Forrás

• Lezárult

  Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.

  NCT05158387· 3. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT05089734· 3. fázis· Gilead Sciences· Forrás

• Lezárult

  A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

  NCT05076149· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Lezárult

  Comparison of Corticosteroids vs Placebo on Duration of Ventilatory Support During Severe Acute Exacerbations of COPD Patients in the ICU

  NCT04163536· 3. fázis· Versailles Hospital· Forrás

• Lezárult

  Predictive Signature of Benralizumab Response

  NCT04565483· 4. fázis· Nantes University Hospital· Forrás

• Lezárult

  A Study of SEA-CD40 Given With Other Drugs in Cancers

  NCT04993677· 2. fázis· Seagen Inc.· Forrás

• Lezárult

  Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer

  NCT05117242· 2. fázis· Genmab A/S· Forrás

• Lezárult

  Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

  NCT04987203· 3. fázis· AVEO Pharmaceuticals, Inc.· Forrás

• Leállították

  Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma

  NCT04854499· 2. fázis· Gilead Sciences· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

  NCT04956692· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients

  NCT04412070· Hopital Foch· Forrás

• Lezárult

  Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS

  NCT04788615· 3. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA

  NCT04822350· Pfizer· Forrás

• Fut, nem toboroz

  Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

  NCT04793958· 3. fázis· Mirati Therapeutics Inc.· Forrás

• Fut, nem toboroz

  A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

  NCT04810078· 3. fázis· Bristol-Myers Squibb· Forrás

• Lezárult

  A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy

  NCT04660344· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis

  NCT04356664· 2/3. fázis· Hopital Foch· Forrás

• Leállították

  HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  NCT03850795· 3. fázis· Hinova Pharmaceuticals USA, Inc.· Forrás

Showing 50 of 77.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Dermatomyositis and polymyositis (myositis)4 munka · 0 vizsgálat